Adial Pharmaceuticals (ADIL) Institutional Ownership $1.01 -0.01 (-0.98%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Adial Pharmaceuticals (NASDAQ:ADIL)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$322.96KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$19.27K Get ADIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Adial Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADIL Institutional Buying and Selling by Quarter Ad StockEarnings9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now Adial Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024 Renaissance Technologies LLC34,346$39K0.0%-32.8%0.811% 5/20/2024 Virtu Financial LLC20,469$27K0.0%N/A0.484% 2/13/2024 Armistice Capital LLC159,000$296K0.0%N/A9.578% 11/9/2023 Manchester Capital Management LLC48,097$134K0.0%-96.0%3.942% 5/9/2023 Manchester Capital Management LLC1,202,452$421K0.1%N/A4.216% 11/7/2022 Virtu Financial LLC77,694$27K0.0%+142.7%0.301% Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/2/2022 Thompson Davis & CO. Inc.21,000$28K0.0%N/A0.088% 7/22/2022 Truist Financial Corp33,862$45K0.0%N/A0.142% 7/13/2022 Private Advisor Group LLC21,400$29K0.0%-37.3%0.090% 11/12/2021 Oppenheimer & Co. Inc.38,500$165K0.0%+37.5%0.190% 11/12/2021 NorthRock Partners LLC10,000$43K0.0%N/A0.049% 10/29/2021Commonwealth Equity Services LLC36,461$156K0.0%+25.5%0.180% 9/17/2021 Virtu Financial LLC31,038$79K0.0%N/A0.153% 8/16/2021 State Street Corp48,954$125K0.0%N/A0.260% 8/13/2021 Northern Trust Corp21,873$56K0.0%N/A0.116% 8/13/2021 Geode Capital Management LLC88,246$225K0.0%+13.2%0.469% 8/13/2021 Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112% 8/11/2021Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155% 8/3/2021 Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152% 7/17/2021Golden Green Inc.24,700$63K0.0%N/A0.134% 5/14/2021 Dimensional Fund Advisors LP31,410$76K0.0%+68.8%0.179% 5/13/2021 Barclays PLC15,850$38K0.0%N/A0.091% 5/12/2021Rede Wealth LLC15,000$36K0.0%N/A0.086% 5/10/2021 Oppenheimer & Co. Inc.14,500$35K0.0%N/A0.083% 5/4/2021Commonwealth Equity Services LLC22,050$53K0.0%+107.3%0.126% 4/22/2021 Private Advisor Group LLC36,650$89K0.0%N/A0.212% 3/8/2021 Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129% 2/25/2021 Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129% 2/10/2021 Renaissance Technologies LLC98,900$168K0.0%+6.5%0.687% 12/11/2020 Virtu Financial LLC18,902$42K0.0%N/A0.131% (Data available from 1/1/2016 forward) ADIL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADIL shares? During the previous two years, the following institutional investors and hedge funds held shares of Adial Pharmaceuticals shares: Armistice Capital LLC ($296K), Manchester Capital Management LLC ($134K), and Renaissance Technologies LLC ($39K), Virtu Financial LLC ($27K).Learn more on ADIL's institutional investors. What percentage of Adial Pharmaceuticals stock is owned by institutional investors? 16.41% of Adial Pharmaceuticals stock is owned by institutional investors. Learn more on ADIL's institutional investor holdings. Which institutional investors have been buying Adial Pharmaceuticals stock? The following institutional investors have purchased Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.20M), Armistice Capital LLC ($159K), and Virtu Financial LLC ($20.47K). How much institutional buying is happening at Adial Pharmaceuticals? Institutional investors have bought a total of 1,381,921 shares in the last 24 months. This purchase volume represents approximately $10.84M in transactions. Which Adial Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.15M), and Renaissance Technologies LLC ($16.75K). How much institutional selling is happening at Adial Pharmaceuticals? Institutional investors have sold a total of 1,171,109 shares in the last 24 months. This volume of shares sold represents approximately $3.23M in transactions. Related Companies Pluri Major Shareholders BioLineRx Major Shareholders Equillium Major Shareholders GeoVax Labs Major Shareholders Athira Pharma Major Shareholders BioXcel Therapeutics Major Shareholders Lakeshore Biopharma Major Shareholders Calidi Biotherapeutics Major Shareholders Lisata Therapeutics Major Shareholders Exicure Major Shareholders This page (NASDAQ:ADIL) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADIL Stock Alerts